Sandoval Elisabeth 4
4 · VYNE Therapeutics Inc. · Filed Jul 20, 2021
Insider Transaction Report
Form 4
Sandoval Elisabeth
Director
Transactions
- Award
Stock Options
2021-07-19+20,500→ 20,500 totalExercise: $2.75Exp: 2031-07-19→ Common Stock (20,500 underlying)
Footnotes (1)
- [F1]These options vest over a 12 month period in equal, monthly installments, ending July 19, 2022.